Zoetis (Belgium)

Zoetis (Belgium)

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Zoetis (Belgium), Belgium, covering academic research published from 2013 to 2024. Read More.


Open Access Percentage

70%


Total
Publications

160


Total Open
Publications

112


Total
Citations

3.3K


Open Access
Percentage

70%


Total
Publications

160


Total Open
Publications

112


Total
Citations

3.3K

Wikipedia

Website

download

Breakdown

23% 38% 9% 30%

Publisher Open

23%

Both

38%

Other Platform Open

9%

Closed

30%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

45

Hybrid 48%

47

No Guarantees 6%

6

Other Platform Open

Domain 69%

52

Institution 36%

27

Preprint 9%

7

Public 8%

6

Other Internet 5%

4

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
50
Europe PMC
Domain
21
Ghent University - Ghent University Academic Bibliography
Institution
13
Semantic Scholar
Public
6
Research Square
Preprint
5
University of Surrey - Surrey Open Research repository
Institution
4
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
4
Queen's University Belfast - Research Portal
Institution
3
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
3
Universitat Autònoma de Barcelona - Dipòsit Digital de Documents de la UAB
Institution
2
1 / 4

Data updated 7 April 2025

Share

Share

Share